ISHIDA; Natsuki
Patent Applications and Registrations
Patent applications and USPTO patent grants for ISHIDA; Natsuki.The latest application filed is for "therapeutic agent for inflammatory diseases, autoimmune diseases, fibrotic diseases, and cancer diseases".
- ISHIDA; Natsuki - Yokohama-shi Kanagawa
- Ishida; Natsuki - Yokohama JP
- Ishida; Natsuki - Tokyo JP
| Patent | Date |
|---|---|
| Therapeutic Agent For Inflammatory Diseases, Autoimmune Diseases, Fibrotic Diseases, And Cancer Diseases App 20210315892 - ISHIDA; Natsuki ; et al. | 2021-10-14 |
| Compound and pharmacologically acceptable salt thereof Grant 10,669,283 - Tamura , et al. | 2020-06-02 |
| Novel Compound And Pharmacologically Acceptable Salt Thereof App 20190322686 - TAMURA; Keiji ; et al. | 2019-10-24 |
| Authentication system in client/server system and authentication method thereof Grant 8,181,234 - Ishida May 15, 2 | 2012-05-15 |
| Authentication System And Authentication Method App 20100017860 - Ishida; Natsuki | 2010-01-21 |
| Verification System App 20070220597 - ISHIDA; Natsuki | 2007-09-20 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 